Navigation Links
InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
Date:11/17/2011

TEL-AVIV, Israel, Nov. 17, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology, today announced that Sol J. Barer, Ph.D., a current member of the Company's board of directors and the former Chairman, and CEO of Celgene Corporation, has been elected the Chairman of InspireMD's Board of Directors, effective immediately. InspireMD thanks Asher Holzer for his contributions as chairman and leading the Company to its current successful stage. Mr. Holzer will continue as President of the Company and a member of the Board of Directors.  

Dr. Barer commented, "Since I joined the Board of Directors mid-year, I have become increasingly impressed with the Company's potential and am very pleased to have been asked to take the Chairman's role. I look forward to working with the Board and management in developing products and securing regulatory approval for life-saving products and positioning the Company for enhanced shareholder value."

Dr. Barer has more than 30 years experience with publicly traded biotechnology companies. In 1980, he was with Celanese Research Company when he formed the biotechnology group that was subsequently spun out to form Celgene. Dr. Barer spent 18 years leading Celgene, holding the positions of president, COO and Chairman and CEO during different periods, culminating with his tenure as Celgene's Executive Chairman before retiring in June of 2011. Celgene's market capitalization at his retirement was approximately $27 billion. Dr. Barer serves on the Board of several companies including: Amicus Therapeutics, Inc., Aegerion Pharmaceuticals, Inc., ContraFect Corp., Cerecor Corp and Edge Therapeutics, Inc. He serves as Chairman of BioNJ Inc., the 300 company biotechnology organization of New Jersey, as Chairman of the Governor of New Jersey's UMDNJ Advisory Committee and advises
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
2. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
3. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
4. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
5. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
6. County of Los Angeles Selects Netsmart to Provide Comprehensive Behavioral Health Information System
7. The American Ceramic Society selects Marshall, Niihara as 2011 Distinguish Life Members
8. H. D. Smith Selects IT Industry Executive David Guzman as CIO
9. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
10. EdgeBio Selects Calipers Sample Preparation Suite for High Throughput and Benchtop Sequencing Workflows
11. St. Lukes Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 Last year, ... Systems , a leading global provider of data management ... with TrialMaster, a leading-edge system for electronic data capture ... of universal design and study execution tools added TrialMaster ... and much anticipated version of Transform for TrialMaster, is ...
(Date:7/23/2014)... 23, 2014  Having the right people at the ... accelerating business growth and achieving clinical and operational goals. ... Leadership Summit, July 20-22, 2014, in San ... executives and healthcare experts discussing how partnerships have positively ... President & Chief Executive Officer of Cape Regional Medical ...
(Date:7/23/2014)... de julio de 2014 ADB International ... ha anunciado hoy una asociación con Austen BioInnovation ... o el Instituto), para el propósito de llevar ... terapia de señal bioeléctrica (el E-QURE BST Device), ... que tiene una importante experiencia en cicatrización de ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 ... cell therapy in the US aimed at improving the ... their newest clinical study for Parkinson’s disease. StemGenex ... of stem cell therapy are paramount when providing care ... clinical study makes stem cell therapy accessible to the ...
Breaking Biology Technology:Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3
... Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico ... ... Oct. 19 The use,of fractional flow reserve (FFR) for optimizing ... Cardiovascular,Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in,Washington. ...
... /Xinhua-PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... in the rapidly growing Chinese marketplace,announced today that ... results,on Monday, November 5, 2007, before the market ... Jinsheng Ren, and chief financial,officer, Frank Zhigang Zhao, ...
... BSX ) today announced financial results for the third,quarter ended ... per share (EPS) for the fourth quarter of 2007. Highlights ... at the mid-point of guidance, and adjusted ... one position in the worldwide drug-eluting stent (DES) ...
Cached Biology Technology:Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 25
(Date:7/23/2014)... 60 billion tons of carbon into the atmosphere each ... burning fossil fuels. This happens through a process called ... by carbon coming into the soil system from falling ... the underground activities of plant roots. , Short-term ... rate of soil respiration. As a result, scientists have ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... blow fly Chrysomya megacephala is commonly found ... to determine the time of death, referred to as ... form of C. megacephala from Tamil Nadu ... features and molecular characterization through generation of DNA barcoding. ... the open access Biodiversity Data Journal . , ...
Breaking Biology News(10 mins):Climate change and the soil 2Protein evolution follows a modular principle 2Dead body feeding larvae useful in forensic investigations 2
... NEW YORK (Feb. 29, 2008) -- Teens who can ... ads are less likely to succumb to alcohol advertising ... a three-year study of inner-city middle school students by ... journal Addictive Behaviors (April print edition). Previous research has ...
... derives from the red jungle fowl, but new research from ... chicken are more complicated than that. The ... legs and found to their surprise that this genetic heredity ... The study is being published today in the Web ...
... discovered how roots find their way past obstacles to grow ... Science, also explains how germinating seedlings penetrate the soil without ... in the fuzzy coat of hairs on the roots of ... control mechanism that enables these hairs to find their way ...
Cached Biology News:Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Darwin was wrong about the wild origin of the chicken 2
... The Sciclone ALH 4000 workstation is the ... seeking to introduce automated liquid handling capabilities,into ... that need to support routine applications on ... and,integrated for walk-away automation even when ...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Life Sciences provides cost effective cell culture ... or monoclonal antibodies. Quality at a reasonable ... you require research or commercial product, we ... methods such as roller bottles, hollow fiber, ...
Biology Products: